Warning: Declaration of My_Walker::start_el(&$output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $data_object, $depth = 0, $args = NULL, $current_object_id = 0) in /home2/ajnrblog/public_html/ajnrdigest/wp-content/themes/ajnr/functions.php on line 258
The Utility of Diffusion-Weighted Imaging for Cholesteatoma Evaluation - AJNR News Digest
January 2014
Review Article

The Utility of Diffusion-Weighted Imaging for Cholesteatoma Evaluation

John I. Lane

John I. Lane

We first became interested in utilizing non-EPI DWI for the detection of recurrent cholesteatomas after reading the published works of our European colleagues.1,2 Clinical diagnosis of recurrence is quite limited in patients following canal wall-up mastoidectomy and tympanoplasty procedures (often performed with opaque cartilaginous grafts), precluding adequate otoscopic inspection of the middle ear. CT is often nondiagnostic unless evidence of bony erosion can be found to suggest recurrence. Surgical re-exploration (second-look surgery) to exclude recurrence at 9–12 months after the initial procedure has been the standard of care for decades. When we approached our neurotology colleagues, they were quite interested in investigating the possibility of replacing second-look surgeries with serial follow-up non-EPI DWI MR examinations to exclude recurrence.

Our initial results at 1.5T were promising and corroborated the results of previously reported studies, leading to a significant practice change in the follow-up of these patients and replacing an invasive surgical procedure with a noninvasive imaging study.3 We felt strongly that it would be useful to disseminate this information more widely by way of a review article for AJNR, and were delighted to respond to an invitation to submit the review.4

Unfortunately, despite reports in the literature to the contrary,5,6 our initial enthusiasm for employing these techniques at 3T have been tempered by the image degradation we observed secondary to increased susceptibility artifact at higher field strength. This is particularly problematic with the

non-EPI HASTE DWI sequence, which has proven to be the most robust sequence available in the detection of recurrent cholesteatoma. Non-EPI RESOLVE DWI (PROPELLER) produces less artifact and greater spatial resolution but, in our experience, has a higher false-negative rate than the HASTE DWI. We are currently working on modifications to reduce susceptibility artifact at higher field strength, but until that is achieved, we preferentially scan all “r/o recurrent cholesteatoma” patients at 1.5T, utilizing both the higher contrast-to-noise of HASTE DWI and the greater spatial resolution of RESOLVE DWI.

References

  1. Dubrulle F, Souillard R, Chechin D, et al. Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma. Radiology 2006;238: 604–10
  2. De Foer B, Vercruysse J-P, Bernaerts A, et al. Detection of postoperative residual cholesteatoma with non-echo-planar diffusion weighted magnetic resonance imaging. Otol Neurotol 2008;29: 513–17. doi: 10.1097/MAO.0b013e31816c7c3b
  3. Schwartz KM, Lane JI, Neff BA, et al. Diffusion-weighted imaging for cholesteatoma evaluationEar Nose Throat J 2010;89:E14–9
  4. Schwartz KM, Lane JI, Bolster BD Jr, et al. The utility of diffusion-weighted imaging for cholesteatoma evaluation.  AJNR Am J Neuroradiol 2011;32:430–36
  5. Pizzini BF, Barbieri F, Beltramello A, et al. HASTE diffusion-weighted 3-Tesla magnetic resonance imaging in the diagnosis of primary and relapsing cholesteatoma. Otol Neurotol 31:596–602. doi: 10.1097/MAO.0b013e3181dbb7c2
  6. Lehmann P, Saliou G, Brochart C, et al. 3T MR imaging of postoperative recurrent middle ear cholesteatomas: value of periodically rotated overlapping parallel lines with enhanced reconstruction diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2009:30;423–27

 

Read this article at AJNR.org . . .